BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesBrandPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsOpen House Discount Contracts for Olodaterol and Tiotropium Bromide
    Open tender

    Open House Discount Contracts for Olodaterol and Tiotropium Bromide

    Tender closes
    329d
    31 Jul 2027 · in 47 weeks

    This contract opportunity involves the establishment of non-exclusive discount contracts for medications containing the active ingredients Olodaterol and Tiotropium Bromide. The contracts will be in effect from October 1, 2025, to September 30, 2027, with the possibility of entering into contracts a

    🇩🇪GermanyPublished 5 Aug 2025· 1 years agoviaTED
    Tender closes
    329d
    31 Jul 2027 · in 47 weeks

    Decision brief

    4 fields
    • Contract value
      Not disclosed
      Source did not declare a figure
    • Tender closes
      31 Jul 2027
      329 days left
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇩🇪Germany

    Lifecycle

    Open

    329 days left to bid. Opened 1 years ago, deadline 31 Jul 2027.

    5 Aug 2025Today31 Jul 2027

    Brief

    This contract opportunity involves the establishment of non-exclusive discount contracts for medications containing the active ingredients Olodaterol and Tiotropium Bromide. The contracts will be in effect from October 1, 2025, to September 30, 2027, with the possibility of entering into contracts at any time during this period (open-house model). Please note that medications listed as children's medicines according to the BfArM list are excluded from this open house procedure. Suppliers interested in providing these medications should refer to the official notice for more details.

    More from AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND

    4 listingsView all →
    Facilities Management🇩🇪Germany

    Framework Agreement for Visitor Chairs

    The AOK Rheinland-Pfalz/Saarland - The Health Fund is issuing a framework agreement for "Seating Furniture" consisting of a total of 4 lots. This specific tender is for Lot 3, which involves establishing a framework agreement for the purchase, delivery to the designated location, assembly/installati

    est.€182,000AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 16 Feb 2026
    AwardedHealthcare & Medical🇩🇪Germany

    Germany – Termination of Open-House Procedure for Pazopanib

    The Open-House procedure for pharmaceutical discount contracts involving the active ingredient Pazopanib (ATC L01EX03), identified by the code "484904-2024", will be terminated effective January 31, 2026. Existing contracts will be canceled at that time, and no new contracts can be concluded under t

    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 10 Dec 2025
    Healthcare & Medical🇩🇪Germany

    Open House Discount Contracts for Glatiramer Acetate

    This contract opportunity involves the establishment of non-exclusive discount contracts for the medication Glatiramer Acetate, specifically for pre-filled syringes. The contracts will be in effect from February 1, 2026, to January 31, 2028, with the option for suppliers to enter into contracts at a

    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 9 Dec 2025
    Healthcare & Medical🇩🇪Germany

    Open House Discount Contracts for Naproxen and Esomeprazole

    This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical products Naproxen and Esomeprazole, in accordance with German social law. The contracts will be valid from February 1, 2026, to January 31, 2028, and suppliers can enter into contracts at

    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 9 Dec 2025

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Medicines Manufacturing Data Institute: Phase 1 Funding

    Apply for up to £500,000 to establish the Medicines Manufacturing Data Institute, a trusted data hub for the medicines ecosystem, with potential for up to £5 million phase 2 funding.

    est.£500,000
    Published 7 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Consultant-Led ENT Services Outsourcing

    UHN seeks a consultant-led ENT service provider to manage comprehensive patient pathways, improve access, and ensure RTT compliance.

    est.£3,000,000KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST
    Published 4 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Central Sterile Services Department Track and Trace System

    A track and trace system to manage sterile instrument and equipment movement throughout the sterilization and distribution process in hospital central sterile services departments.

    est.£250,000Guy's and St Thomas' NHS Foundation Trust
    Published 4 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Inpatient Detoxification Services for Substance Users - Market Consultation

    Leicester City Council is seeking provider input through a Soft Market Test to inform future commissioning of inpatient detoxification services for people using drugs and alcohol.

    £1nominalLEICESTER CITY COUNCIL
    Published 4 Sept 2026
    Take action
    View tender on sourceTED

    Full notice and submission process on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    516018-2025
    AR
    Buyer
    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Sector
    Healthcare & Medical